Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

DrMedHealth vs Hers

DrMedHealth and Hers both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
DrMedHealth logo

DrMedHealth

6.2
★★★☆☆3.1/5

Best for: seeing what it charges before you answer any medical questions

Visit DrMedHealth →
VS
Hers logo

Hers

6.6
★★★☆☆3.3/5

Best for: coverage in all 50 states, which most sellers will not confirm

Visit Hers →

If you are choosing between DrMedHealth and Hers, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Hers leads our six-part score, 6.6 to 6.2. Both have drawn an FDA warning letter.

DrMedHealth vs Hers price

DrMedHealth and Hers start at the same figure, $199 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.

Drug by drug: Semaglutide costs the same at both, $199 a month; tirzepatide costs the same at both, $299 a month.

Medications and formats

Both sell semaglutide and tirzepatide.

On format, DrMedHealth prices compounded injections, while Hers prices compounded injections and brand-name pens.

If you want the FDA-approved brand rather than a compounded version, Hers is the only one of the two with a brand-name price.

Where each one treats patients

DrMedHealth does not publish where it ships, and Hers lists 50 states.

Pricing

DrMedHealth

startingCompounded
$199/mo
semaglutide
startingCompounded
$299/mo
tirzepatide

Hers

StartingCompounded
$199/mo
semaglutide
StartingBrand-name
$299/mo
tirzepatide

Brand Zepbound from $299/mo medication-only; requires Hers Weight Loss Membership ($149/mo)

What each price covers

Both prices cover the medication itself.

DrMedHealth's price also covers the clinician visit and shipping, which Hers does not claim.

DrMedHealth is silent on lab work and coaching.

Hers is silent on shipping and lab work.

DrMedHealth

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Hers

Covered by the monthly price

Medication

In the price

Clinician visits

Charged on top

Shipping

Not stated

Lab work

Not stated

Coaching

Charged on top

Where each one scores higher

Overall, Hers scores 6.6 and DrMedHealth 6.2 out of 10.

DrMedHealth is stronger on support (7.0 vs 3.0).

Hers is stronger on trust & safety (5.5 vs 3.5) and accessibility (10.0 vs 5.0).

Value, effectiveness and user experience are within half a point.

How we score

DrMedHealth

6.2/10

Overall

Hers

6.6/10

Value25%

3.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

3.5A
vs
B
5.5

Accessibility10%

5.0A
vs
B
10.0

Support10%

7.0A
vs
B
3.0

FDA warning letters

The FDA sent DrMedHealth a warning letter dated June 8, 2026 (letter 728278), and it is still open.

The FDA sent Hers a warning letter dated September 9, 2025 (letter 716825), and it is still open.

Features & Coverage

FeatureDrMedHealthHers
Starting Price$199/mo$199/mo
Features✓8 features2 features
States AvailableNot disclosed50
Compounded✓ Yes✓ Yes
Brand Name—✓ Yes
FSA/HSA Accepted——
FDA Warning Letters1 letter1 letter

About DrMedHealth

At DrMedHealth $199/mo opens compounded semaglutide and $299/mo compounded tirzepatide, with FDA-approved Ozempic, Wegovy and Mounjaro stocked under their brand names. Physicians who are board-certified do the prescribing, and the platform advertises a roughly 2-hour physician review with delivery thrown in. Licensed US pharmacies prepare the compounded material. LegitScript certification is held, and coverage spreads over many states through dedicated pages for California, Michigan, Indiana, Utah and elsewhere. Quality, safety and efficacy of compounded GLP-1s carry no FDA approval.

Read our full DrMedHealth review →

About Hers

Hers is the women-focused telehealth brand from Hims and Hers. It sells compounded semaglutide on a 6-month plan.

Read our full Hers review →

Pros & Cons

DrMedHealth

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits and shipping

Watch-outs

  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • The FDA has issued DrMedHealth a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Hers

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication
  • Serves all 50 states

Watch-outs

  • Not included in the monthly price: clinician visits, coaching
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • The FDA has issued Hers a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Hers

Hers wins this one, 6.6 to 6.2, above all for coverage in all 50 states, which most sellers will not confirm. DrMedHealth fits better if seeing what it charges before you answer any medical questions is your priority.

Choose DrMedHealth if…

You want seeing what it charges before you answer any medical questions and an opening price near $199 a month.

Choose Hers if…

You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.2

YourEra

Semaglutide at $99/month, 63% below the typical price

8.7

Gala

Moving between compounded and brand without changing seller

9.0

CoreAge Rx

Semaglutide at $99/month, 48% below the typical price

DrMedHealth vs Hers: FAQ

Neither on the entry price: DrMedHealth and Hers both start at about $199 a month. The difference is in what the price includes.
Yes, both sell semaglutide and tirzepatide.
DrMedHealth does not publish where it ships; Hers lists 50 states. Confirm your state before paying.
Both include the medication itself. Only DrMedHealth includes the clinician visit and shipping.
DrMedHealth has an open FDA warning letter from June 8, 2026. Hers has an open FDA warning letter from September 9, 2025.
No. Neither DrMedHealth nor Hers pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.